Sverige - svenska - Läkemedelsverket (Medical Products Agency)

meda ab - magnesiumcitrat (vattenfritt); magnesiumlaktatdihydrat - tuggtablett - 120 mg - isomalt hjälpämne; aspartam hjälpämne; sorbitol hjälpämne; magnesiumcitrat (vattenfritt) 125 mg aktiv substans; magnesiumlaktatdihydrat 1078 mg aktiv substans - magnesium (olika salter i kombination)

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

eql pharma ab - magnesiumhydroxid - tablett - 250 mg - magnesiumhydroxid 600 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - magnesiumhydroxid - tablett - 250 mg - magnesiumhydroxid 600 mg aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris ab - magnesiumhydroxid - tablett - 250 mg - magnesiumhydroxid 600 mg aktiv substans - magnesiumhydroxid

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - kalciumkarbonat; magnesiumhydroxid - tuggtablett - 180 mg / 43,7 mg - kalciumkarbonat 450,51 mg aktiv substans; magnesiumhydroxid 104,85 mg aktiv substans; sorbitol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europeiska unionen - svenska - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

baxter medical ab - glukosmonohydrat; kaliumklorid; magnesiumkloridhexahydrat; natriumacetattrihydrat; natriumklorid - infusionsvätska, lösning - magnesiumkloridhexahydrat 0,3 mg aktiv substans; kaliumklorid 1,5 mg aktiv substans; natriumacetattrihydrat 3,13 mg aktiv substans; natriumklorid 1 mg aktiv substans; glukosmonohydrat 55 mg aktiv substans - elektrolyter och kolhydrater

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

baxter medical ab - glukosmonohydrat; kalciumkloriddihydrat; magnesiumkloridhexahydrat; natriumklorid; natriumlaktat; natriumvätekarbonat - peritonealdialysvätska - 22,7 mg/ml - magnesiumkloridhexahydrat 0,14 mg aktiv substans; natriumlaktat 1,76 mg aktiv substans; natriumvätekarbonat 3,29 mg aktiv substans; natriumklorid 8,89 mg aktiv substans; glukosmonohydrat 68,85 mg aktiv substans; kalciumkloriddihydrat 0,71 mg aktiv substans - hypertona lösningar